LYMPHOMA, MANTLE-CELL
Clinical trials for LYMPHOMA, MANTLE-CELL explained in plain language.
Never miss a new study
Get alerted when new LYMPHOMA, MANTLE-CELL trials appear
Sign up with your email to follow new studies for LYMPHOMA, MANTLE-CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill targets tough blood cancers after standard treatments fail
Disease control OngoingThis early-stage study is testing the safety and initial effectiveness of a new oral drug called LOXO-338 for patients with advanced blood cancers like leukemia and lymphoma who have already received standard therapies. The trial has two parts: first testing LOXO-338 alone, and t…
Matched conditions: LYMPHOMA, MANTLE-CELL
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Major trial aims to extend remission for aggressive blood cancer
Disease control OngoingThis large, late-stage study is testing whether adding a newer targeted drug (acalabrutinib) to a standard two-drug chemotherapy regimen (bendamustine and rituximab) works better for people newly diagnosed with mantle cell lymphoma. It will compare how long patients live without …
Matched conditions: LYMPHOMA, MANTLE-CELL
Phase: PHASE3 • Sponsor: Acerta Pharma BV • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC